Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.

Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
Curr Alzheimer Res. 2019;16(7):659-674
Authors: Wang H, Shen Y, Chuang H, Chiu C, Ye Y, Zhao L
Abstract
Alzheimer's disease is the world's most common dementing illness. It is pathologically characterized by β-amyloid accumulation, extracellular senile plaques and intracellular neurofibrillary tangles formation, and neuronal necrosis and apoptosis. Neuroinflammation has been widely recognized as a crucial process that participates in AD pathogenesis. In this review, we briefly summarized the involvement of microglia in the neuroinflammatory process of Alzheimer's disease. Its roles in the AD onset and progression are also discussed. Numerous molecules, including interleukins, tumor necrosis factor alpha, chemokines, inflammasomes, participate in the complex process of AD-related neuroinflammation and they are selectively discussed in this review. In the end of this paper from an inflammation- related perspective, we discussed some potential therapeutic choices.
PMID: 31580243 [PubMed - in process]

Source: Current Alzheimer Research - October 5, 2019 Category: Neurology Authors: Wang H, Shen Y, Chuang H, Chiu C, Ye Y, Zhao L Tags: Curr Alzheimer Res Source Type: research